Evidence is conflicting on the prognostic value of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in head and neck squamous cell carcinoma. The aim of our study was to determine the impact of semiquantitative and qualitative metabolic parameters on the outcome in patients managed with standard treatment for locally advanced disease.
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis / Bonomo, Pierluigi; Merlotti, A; Olmetto, E; Bianchi, A; Desideri, I; Bacigalupo, A; Franco, P; Franzese, C; Orlandi, E; Livi, L; Caini, S. - In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1619-7089. - ELETTRONICO. - (2018), pp. 1-17. [10.1007/s00259-018-4065-5]
What is the prognostic impact of FDG PET in locally advanced head and neck squamous cell carcinoma treated with concomitant chemo-radiotherapy? A systematic review and meta-analysis
Bonomo, Pierluigi;Olmetto, E;Desideri, I;Franzese, C;Livi, L;Caini, S
2018
Abstract
Evidence is conflicting on the prognostic value of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in head and neck squamous cell carcinoma. The aim of our study was to determine the impact of semiquantitative and qualitative metabolic parameters on the outcome in patients managed with standard treatment for locally advanced disease.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Bonomo2018_Article_WhatIsThePrognosticImpactOfFDG.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
894.95 kB
Formato
Adobe PDF
|
894.95 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
